IP Library Granted Patent US 8,877,493
Granted Patent B2
US 8,877,493 · App. 13/500,452 · Granted Nov 4, 2014

Culture substrate for human pluripotent stem cells and use thereof

Inventors: Kiyotoshi Sekiguchi (Osaka, JP); Sugiko Futaki (Osaka, JP); Yukimasa Taniguchi (Osaka, JP); Maria Hayashi (Osaka, JP); Norio Nakatsuji (Kyoto, JP); Takamichi Miyazaki (Kyoto, JP); Eihachiro Kawase (Kyoto, JP); Hirofumi Suemori (Kyoto, JP)
Assignees: Osaka University; Kyoto University
C12N5/0606C12N5/0696C12N2533/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,493
App. No.
13/500,452
Granted
Nov 4, 2014
Kind
B2
Abstract

The present invention provides a culture substrate which enables maintenance culture of human pluripotent stem cells in a pluripotent state under a feeder-free culture environment, and a culture method of human pluripotent stem cells using the culture substrate. By seeding human pluripotent stem cells dissociated into single cells at a cell density of 4×10 4 to 10×10 4 cells/cm 2 onto a culture substrate coated with human laminin α5β1γ1 E8 fragment or human laminin α3β3γ2 E8 fragment preferably at a concentration of 0.5 to 25 μg/cm 2 , the human pluripotent stem cells can be rapidly expanded in a pluripotent state.

Claims (9)

1. A culture method of human pluripotent stem cells dissociated into single cells in feeder-free culture conditions, comprising the steps of:

dissociating human pluripotent stem cells into single cells, and

culturing the human pluripotent stem cells dissociated into single cells using a culture substrate, the culture substrate being coated with human laminin β5β2γ1 E8 fragment or human laminin α3β3γ2 E8 fragment.

2. The culture method according to claim 1 , wherein the coating concentration of human laminin α5β1γ1 E8 fragment or human laminin α3β3γ2 E8 fragment is 0.5 to 25 μg/cm 2 .

3. The culture method according to claim 1 , wherein the human pluripotent stem cell are human ES cells or human iPS cells.

4. The culture method according to claim 1 , wherein the human pluripotent stem cells dissociated into single cells are seeded at a cell density of 2×10 4 to 20×10 4 cells/cm 2 .

5. The culture method according to claim 1 , further comprising forming single-cell-derived colonies through culturing the human pluripotent stem cells dissociated into single cells.

6. The culture method according to claim 1 , further comprising maintaining the human pluripotent stem cells in a single-cell state.

7. The culture method according to claim 1 , further comprising using a synthetic medium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2012
From: SEKIGUCHI, KIYOTOSHI; FUTAKI, SUGIKO; TANIGUCHI, YUKIMASA; HAYASHI, MARIA; NAKATSUJI, NORIO; MIYAZAKI, TAKAMICHI; KAWASE, EIHACHIRO; SUEMORI, HIROFUMI
To: OSAKA UNIVERSITY; KYOTO UNIVERSITY
Reel/Frame 028207/0505 →
Priority Claims (1)
JP 2009-234583 · Oct 8, 2009 · national
Continuity (1)
Related Publication 20120220031A1 · Aug 30, 2012